To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BARD1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
230 supporting clones for gene BARD1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB088853 testis .a 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
CR740333 germinal center B cell .a 5 to 476 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
AK223409   .a 7 to 2582 1 to 2576 P24S C78Y S131G R378S E587G ...     2576/2576
(100 %)
13 diff
(99.5 %id)
AU098416   .a 7 to 300 1 to 294       294/300
(98 %)
5 diff
(98.4 %id)
AU102584   .a 7 to 56 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
BP204762 coronary artery .a 7 to 588 1 to 582       582/582
(100 %)
9 diff
(98.5 %id)
NM_000465.2   .a 8 to 2599 1 to 2592 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2592/2592
(100 %)
0 diff
(100 %id)
AL703730 human skeletal muscle .a 11 to 609 1 to 600       600/600
(100 %)
7 diff
(98.9 %id)
CB989108 Human Placenta, placenta .a 16 to 600 27 to 611       585/648
(90 %)
1 diff
(99.9 %id)
BM153043 leukopheresis .a 28 to 505 1 to 478       478/482
(99 %)
11 diff
(97.8 %id)
DC345523 tongue, tumor tissue .a 29 to 589 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
AU133243   .a 30 to 788 2 to 760   capped   759/759
(100 %)
5 diff
(99.4 %id)
DC365168   .a 40 to 602 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
AU102585   .a 40 to 89 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
AU077058   .a 40 to 192 1 to 152       152/152
(100 %)
6 diff
(96.1 %id)
AK314260   .a 41 to 2476 1 to 2436 N138S R378S V507M     2436/2436
(100 %)
6 diff
(99.8 %id)
DC349326   .a 41 to 595 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
BP383551   .a 41 to 426 1 to 386       386/386
(100 %)
9 diff
(97.7 %id)
CD579467 brain .a 42 to 818 1 to 771       771/887
(86 %)
46 diff
(94.9 %id)
DN996649 breast cancer, Mammary gland (cancer tissue) .a 42 to 746 7 to 711       705/711
(99 %)
2 diff
(99.8 %id)
AA357614 Prostate .a 48 to 191 1 to 143       143/143
(100 %)
4 diff
(97.3 %id)
CR621362 HeLa cells Cot 25-normalized .a 48 to 1713 1 to 1666   tiling clone,   1666/1666
(100 %)
0 diff
(100 %id)
BX342373   .a 48 to 980 1 to 932   fully sequenced,   932/932
(100 %)
6 diff
(99.4 %id)
AA182509 brain, neuroepithelial cells .a 48 to 554 1 to 508       508/509
(99 %)
20 diff
(96.1 %id)
AA224530 brain, neuroepithelial cells .a 48 to 252 1 to 205       205/205
(100 %)
7 diff
(96.6 %id)
AA114268 Pancreas .a 49 to 436 1 to 392       388/392
(98 %)
16 diff
(96.0 %id)
CB961293 Human Placenta, placenta .a 50 to 722 29 to 708       680/791
(85 %)
14 diff
(98.3 %id)
BQ948842 sciatic nerve .a 60 to 952 1 to 901       901/936
(96 %)
27 diff
(97.2 %id)
AX794378   .a 70 to 2599 1 to 2530 R406Q tiling clone,   2530/2530
(100 %)
3 diff
(99.9 %id)
U76638   .a 70 to 2599 1 to 2530 R406Q     2530/2530
(100 %)
3 diff
(99.9 %id)
BC126426 Brain, cerebellum, PCR rescued clones .a 73 to 2531 1 to 2459 exact     2459/2459
(100 %)
2 diff
(100.0 %id)
BC126428 Brain, cerebellum, PCR rescued clones .a 73 to 2531 1 to 2459 P24S R378S V507M     2459/2459
(100 %)
7 diff
(99.8 %id)
TI_1520872067   .a 73 to 1264 50 to 1230       1181/1237
(95 %)
35 diff
(97.2 %id)
AA641778 germinal center B cell .a 108 to 388 1 to 268   fully sequenced,   268/268
(100 %)
13 diff
(95.2 %id)
DB078251 testis .a 124 to 668 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB457930 testis .a 211 to 709 1 to 499       499/499
(100 %)
0 diff
(100 %id)
AI381555 pooled .a 227 to 758 531 to 1       531/531
(100 %)
4 diff
(99.3 %id)
DA756744   .a 248 to 799 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
AA815147 germinal center B cell .a 301 to 765 468 to 3       466/476
(97 %)
12 diff
(97.5 %id)
AA651816 germinal center B cell .a 327 to 765 440 to 2   fully sequenced,   439/440
(99 %)
0 diff
(100 %id)
AA913600 pooled .a 371 to 750 380 to 1       380/380
(100 %)
0 diff
(100 %id)
AV763374 bone marrow .a 372 to 809 1 to 435       435/436
(99 %)
3 diff
(99.4 %id)
AA356407   .a 409 to 801 1 to 396       396/399
(99 %)
14 diff
(96.5 %id)
FN103597 breast carcinoma .a 435 to 491 1 to 57       57/60
(95 %)
3 diff
(95.0 %id)
BE887380 leiomyosarcoma, uterus .a 445 to 1201 1 to 750       750/945
(79 %)
17 diff
(98.3 %id)
AW265349 normal squamous epithelium, tongue .a 500 to 776 284 to 8       277/284
(97 %)
0 diff
(100 %id)
BQ222953 melanotic melanoma, skin .a 500 to 1354 11 to 867       857/867
(98 %)
0 diff
(100 %id)
GD136352   .a 501 to 758 8 to 276   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 269/287
(93 %)
4 diff
(98.7 %id)
AA767871 germinal center B cell .a 502 to 756 259 to 4       256/259
(98 %)
0 diff
(100 %id)
CB157685 Liver .a 539 to 758 1 to 220   AAA   220/220
(100 %)
0 diff
(100 %id)
DA820118   .a 540 to 1101 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
TI_1520874027   .a 629 to 1823 1 to 1185       1185/1280
(92 %)
24 diff
(98.2 %id)
C75170   .a 707 to 1121 43 to 459       417/459
(90 %)
0 diff
(100 %id)
TI_1520873155   .a 713 to 1938 10 to 1231       1222/1297
(94 %)
18 diff
(98.7 %id)
TI_1520873141   .a 713 to 1945 9 to 1241       1233/1305
(94 %)
20 diff
(98.5 %id)
DA679790   .a 757 to 1313 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BQ787057 Pancreas, Purified pancreatic islet .a 779 to 1416 10 to 647       638/648
(98 %)
2 diff
(99.7 %id)
BP252452 Kidney .a 811 to 1395 1 to 585       585/585
(100 %)
0 diff
(100 %id)
CK902332 Pancreas, Purified pancreatic islet .a 820 to 1400 1 to 581     Submitted on the opposite strand 581/581
(100 %)
1 diff
(99.9 %id)
BM562698 duodenal adenocarcinoma, cell line, small intestine .a 864 to 1717 1 to 856       856/1029
(83 %)
22 diff
(97.9 %id)
FN116774 breast carcinoma .a 878 to 980 100 to 1     Submitted on the opposite strand 100/100
(100 %)
3 diff
(97.0 %id)
AA261880 germinal center B cell .a 908 to 1037 1 to 130       130/130
(100 %)
1 diff
(99.3 %id)
BM790340 Ascites, stomach .a 919 to 1501 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BX342372   .a 950 to 1713 764 to 1   fully sequenced,   764/764
(100 %)
6 diff
(99.3 %id)
TI_1520874055   .a 993 to 2213 1211 to 4       1208/1274
(94 %)
16 diff
(98.8 %id)
AW969679   .a 1010 to 1632 71 to 692       622/692
(89 %)
8 diff
(98.9 %id)
FN155966 breast carcinoma .a 1021 to 1124 1 to 104       104/104
(100 %)
0 diff
(100 %id)
DA003014   .a 1034 to 1592 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
TI_1520873137   .a 1040 to 2258 5 to 1216       1212/1278
(94 %)
21 diff
(98.4 %id)
TI_1520873151   .a 1049 to 2143 12 to 1105       1094/1275
(85 %)
7 diff
(99.5 %id)
AL700258 human skeletal muscle .a 1164 to 1700 1 to 537       537/537
(100 %)
4 diff
(99.3 %id)
DB080863 testis .a 1196 to 1767 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
FN135638 breast carcinoma .a 1207 to 1313 1 to 112       112/114
(98 %)
6 diff
(94.8 %id)
TI_1520872073   .a 1369 to 2531 1218 to 72       1150/1218
(94 %)
27 diff
(97.8 %id)
TI_1520874835   .a 1375 to 2532 1208 to 71       1146/1270
(90 %)
17 diff
(98.7 %id)
TI_1520874837   .a 1455 to 2531 1142 to 73       1070/1276
(83 %)
8 diff
(99.4 %id)
BM473245 duodenal adenocarcinoma, cell line, small intestine .a 1477 to 2134 1 to 658       658/1152
(57 %)
11 diff
(99.1 %id)
TI_1520873147   .a 1604 to 2532 1 to 929       929/1256
(73 %)
7 diff
(99.5 %id)
TI_1520873135   .a 1605 to 2531 1 to 927       927/1256
(73 %)
8 diff
(99.4 %id)
BE883779 leiomyosarcoma, uterus .a 1614 to 2354 1 to 742       742/767
(96 %)
11 diff
(98.6 %id)
AW601872 breast .a 1615 to 2196 582 to 1       582/582
(100 %)
3 diff
(99.5 %id)
BX098964 liver and spleen .a 1619 to 2279 1 to 661       661/661
(100 %)
0 diff
(100 %id)
R09797 liver and spleen .a 1620 to 1819 1 to 201       201/363
(55 %)
2 diff
(99.5 %id)
AA010484 liver and spleen .a 1660 to 1923 1 to 265       265/289
(91 %)
3 diff
(99.0 %id)
BG187909   .a 1705 to 2076 1 to 369       367/369
(99 %)
10 diff
(97.3 %id)
BQ643252 lymph, lymphoma, cell line .a 1709 to 2569 1 to 870       870/938
(92 %)
18 diff
(98.1 %id)
BG209285   .a 1718 to 2380 12 to 679       668/783
(85 %)
21 diff
(97.4 %id)
TI_149277151   .a 1770 to 2599 903 to 83   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 823/991
(83 %)
11 diff
(98.9 %id)
EC574028 Prostate .a 1793 to 1878 17 to 102       86/102
(84 %)
0 diff
(100 %id)
BU677525 lung, Primary Lung Epithelial Cells .a 1896 to 2599 721 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 703/703
(100 %)
1 diff
(99.9 %id)
BF062272 pooled germ cell tumors .a 1936 to 2599 665 to 1       665/681
(97 %)
52 diff
(92.4 %id)
AW002440 pooled germ cell tumors .a 1952 to 2599 649 to 1       649/649
(100 %)
9 diff
(98.7 %id)
CN277499 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1971 to 2220 1 to 250       250/250
(100 %)
0 diff
(100 %id)
BQ786789 Pancreas, Purified pancreatic islet .a 1973 to 2599 627 to 1       627/627
(100 %)
0 diff
(100 %id)
CB121318 cervix, Uterine .a 1993 to 2541 1 to 549       549/549
(100 %)
3 diff
(99.5 %id)
BG220332   .a 2040 to 2372 1 to 336       336/336
(100 %)
13 diff
(96.2 %id)
AU154612   .a 2046 to 2597 552 to 3       550/555
(99 %)
3 diff
(99.5 %id)
FN085092 breast carcinoma .a 2080 to 2167 1 to 89       89/89
(100 %)
1 diff
(98.9 %id)
AW340207 pooled .a 2099 to 2573 475 to 1       475/475
(100 %)
8 diff
(98.4 %id)
AW340307 pooled .a 2099 to 2599 501 to 1       501/501
(100 %)
1 diff
(99.9 %id)
AA558464 germ cell tumor .a 2122 to 2599 478 to 1       478/478
(100 %)
0 diff
(100 %id)
DB523427 testis .a 2128 to 2599 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
AA181776 brain, neuroepithelial cells .a 2143 to 2600 457 to 1   tiling clone,   457/462
(98 %)
9 diff
(98.1 %id)
AA262794 germinal center B cell .a 2144 to 2599 456 to 1       456/471
(96 %)
1 diff
(99.8 %id)
BG206975   .a 2168 to 2330 26 to 187       162/187
(86 %)
0 diff
(100 %id)
AA113204 Pancreas .a 2171 to 2599 435 to 1       435/436
(99 %)
6 diff
(98.7 %id)
BG190524   .a 2176 to 2417 35 to 275       241/275
(87 %)
0 diff
(100 %id)
TI_1520873159   .a 2196 to 2532 1 to 338       338/1276
(26 %)
6 diff
(99.6 %id)
AA224228 brain, neuroepithelial cells .a 2212 to 2598 388 to 1       388/391
(99 %)
2 diff
(99.5 %id)
AA010398 liver and spleen .a 2249 to 2599 355 to 1       355/355
(100 %)
4 diff
(98.9 %id)
R12387 liver and spleen .a 2300 to 2599 304 to 1       304/314
(96 %)
4 diff
(98.8 %id)
FN060663 breast carcinoma .a 2316 to 2410 1 to 95       95/95
(100 %)
0 diff
(100 %id)
FN116371 breast carcinoma .a 2544 to 2596 1 to 52       52/53
(98 %)
2 diff
(96.3 %id)
AK301843 testis .b 1 to 2257 1 to 2257 K9E R234S tiling clone,   2257/2257
(100 %)
6 diff
(99.8 %id)
DC395614 testis .b 1 to 601 1 to 602       602/602
(100 %)
5 diff
(99.2 %id)
BU187254 eye, retinoblastoma .b 65 to 830 1 to 796   tiling clone,   760/894
(85 %)
52 diff
(94.2 %id)
BM803741 leiomyosarcoma, uterus .b 1974 to 2964 12 to 1021   tiling clone,   1010/1068
(94 %)
56 diff
(94.8 %id)
DA267438 caudate nucleus .b 2344 to 2868 2 to 526   tiling clone, capped   525/525
(100 %)
6 diff
(98.9 %id)
BI254402 cervical carcinoma cell line, cervix .b 2617 to 3157 1 to 570       570/763
(74 %)
32 diff
(95.9 %id)
AV736154 cord Blood .b 2665 to 2951 322 to 43   AAA Submitted on the opposite strand 280/322
(86 %)
0 diff
(100 %id)
AV740372 cord Blood .b 2665 to 2849 176 to 1     Submitted on the opposite strand 176/176
(100 %)
7 diff
(96.1 %id)
DA568357 whole embryo, mainly head .b 2665 to 3369 2 to 708   tiling clone, capped   707/707
(100 %)
3 diff
(99.6 %id)
BG149616 carcinoid, lung .b 2676 to 3139 1 to 464     Submitted on the opposite strand 464/464
(100 %)
4 diff
(99.2 %id)
AA331247 Embryo, 8 weeks .b 2680 to 2954 1 to 275       275/275
(100 %)
0 diff
(100 %id)
FN150643 breast carcinoma .b 2680 to 2767 1 to 88       88/88
(100 %)
0 diff
(100 %id)
AA256070 germinal center B cell .b 2680 to 2827 1 to 148     Submitted on the opposite strand 148/148
(100 %)
0 diff
(100 %id)
AI203206 pooled germ cell tumors .b 2680 to 2997 1 to 318     Submitted on the opposite strand 318/318
(100 %)
1 diff
(99.7 %id)
BF592821 pooled germ cell tumors .b 2680 to 3168 1 to 489     Submitted on the opposite strand 489/489
(100 %)
0 diff
(100 %id)
AW965255   .b 2681 to 3254 1 to 572       572/573
(99 %)
10 diff
(98.3 %id)
AW968107   .b 2681 to 3368 1 to 694       694/694
(100 %)
21 diff
(97.0 %id)
BE771651 prostate_tumor .b 2845 to 3239 438 to 39       400/451
(88 %)
0 diff
(100 %id)
BE895059 melanotic melanoma, skin .b 2890 to 3558 1 to 684       684/759
(90 %)
22 diff
(97.2 %id)
FN097215 breast carcinoma .b 2896 to 2968 71 to 1     Submitted on the opposite strand 71/72
(98 %)
2 diff
(97.3 %id)
BG171632 hypernephroma, cell line, Kidney .b 2968 to 3688 1 to 710       710/964
(73 %)
23 diff
(97.7 %id)
BQ429974 melanotic melanoma, skin .b 2971 to 3519 1 to 555       555/1065
(52 %)
40 diff
(96.3 %id)
FN161798 breast carcinoma .b 2988 to 3057 70 to 1     Submitted on the opposite strand 70/71
(98 %)
0 diff
(100 %id)
BG403619 bladder, transitional cell papilloma, cell line .b 3021 to 3811 1 to 779   tiling clone,   779/779
(100 %)
17 diff
(97.9 %id)
FN095367 breast carcinoma .b 3077 to 3204 121 to 2     Submitted on the opposite strand 120/121
(99 %)
0 diff
(100 %id)
CF139022 CNCAP(3)T-225 cell line, Prostate .b 3101 to 3591 1 to 491       491/491
(100 %)
7 diff
(98.6 %id)
TI_154169207   .b 3108 to 3611 80 to 583       504/504
(100 %)
2 diff
(99.7 %id)
BF977261 melanotic melanoma, high MDR, skin .b 3206 to 3834 1 to 627       627/716
(87 %)
21 diff
(97.1 %id)
FN079605 breast carcinoma .b 3227 to 3288 1 to 62       62/63
(98 %)
1 diff
(98.5 %id)
BY997354   .b 3248 to 3926 8 to 686       679/686
(98 %)
1 diff
(99.9 %id)
BF367156 placenta_normal .b 3255 to 3365 110 to 1       110/111
(99 %)
1 diff
(99.1 %id)
BQ369695 placenta_normal .b 3255 to 3402 158 to 15       144/159
(90 %)
0 diff
(100 %id)
DA493041 brain .b 3268 to 3841 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
FN093106 breast carcinoma .b 3273 to 3345 1 to 72       72/73
(98 %)
2 diff
(97.3 %id)
FN071059 breast carcinoma .b 3304 to 3385 1 to 85       85/85
(100 %)
4 diff
(95.3 %id)
AW367843 head_neck .b 3335 to 3846 530 to 18       513/530
(96 %)
0 diff
(100 %id)
AA256061 germinal center B cell .b 3371 to 3865 496 to 2     Submitted on the opposite strand 495/496
(99 %)
0 diff
(100 %id)
BU853748 testis .b 3398 to 4078 1 to 681       681/778
(87 %)
7 diff
(99.2 %id)
AW023274 cochlea, ear .b 3426 to 3859 8 to 442       435/442
(98 %)
0 diff
(100 %id)
BE940078 uterus_tumor .b 3435 to 3848 26 to 438       413/438
(94 %)
0 diff
(100 %id)
BE698744 uterus_tumor .b 3442 to 3834 403 to 7       397/403
(98 %)
0 diff
(100 %id)
CV572096 cornea, eye .b 3448 to 4033 1 to 586   tiling clone,   586/586
(100 %)
0 diff
(100 %id)
BF196237 carcinoid, lung .b 3462 to 3897 1 to 436     Submitted on the opposite strand 436/436
(100 %)
10 diff
(97.8 %id)
BG112999 Bone, osteosarcoma, cell line .b 3466 to 4137 27 to 695       669/924
(72 %)
12 diff
(98.8 %id)
AW968105   .b 3522 to 3865 379 to 36     Submitted on the opposite strand 344/384
(89 %)
0 diff
(100 %id)
H06002 whole brain .b 3646 to 4036 1 to 398       398/398
(100 %)
8 diff
(98.0 %id)
BX112694   .b 3684 to 4275 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
TI_149272429   .b 3708 to 4331 739 to 116       624/1093
(57 %)
0 diff
(100 %id)
BU675064 lung, Primary Lung Epithelial Cells .b 3708 to 4331 641 to 18       624/642
(97 %)
0 diff
(100 %id)
AA397769   .b 3709 to 4108 1 to 399   fully sequenced,   399/399
(100 %)
0 diff
(100 %id)
CA442865 Fibrosarcoma .b 3709 to 4480 787 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 769/769
(100 %)
4 diff
(99.5 %id)
BU195478 eye, retinoblastoma .b 3723 to 4320 26 to 623   AAA   598/634
(94 %)
22 diff
(96.6 %id)
FN103769 breast carcinoma .b 3725 to 3838 1 to 109       109/109
(100 %)
8 diff
(92.7 %id)
AA215307 germinal center B cell .b 3731 to 4175 1 to 448   fully sequenced,   448/448
(100 %)
3 diff
(99.4 %id)
AA213546 germinal center B cell .b 3738 to 4013 1 to 279       279/279
(100 %)
2 diff
(99.3 %id)
FN057934 breast carcinoma .b 3762 to 3866 106 to 1     Submitted on the opposite strand 106/106
(100 %)
1 diff
(99.1 %id)
DB354858 whole embryo, mainly head .b 3814 to 4330 514 to 1       514/516
(99 %)
4 diff
(99.3 %id)
BE714215 head_neck .b 3833 to 4101 276 to 7       270/276
(97 %)
0 diff
(100 %id)
BE714222 head_neck .b 3833 to 4101 276 to 7       270/276
(97 %)
0 diff
(100 %id)
AI686314 Prostate .b 3836 to 4330 495 to 1       495/495
(100 %)
2 diff
(99.6 %id)
AI983034 brain, three pooled meningiomas .b 3839 to 4330 493 to 1       493/493
(100 %)
3 diff
(99.4 %id)
BE714344 head_neck .b 3842 to 4097 257 to 1       257/257
(100 %)
4 diff
(98.5 %id)
BE714212 head_neck .b 3846 to 4101 1 to 256       256/262
(97 %)
1 diff
(99.7 %id)
BE714216 head_neck .b 3846 to 4110 267 to 4       264/267
(98 %)
0 diff
(100 %id)
BE714258 head_neck .b 3846 to 4110 279 to 16       264/279
(94 %)
0 diff
(100 %id)
BE714284 head_neck .b 3846 to 4101 1 to 259       259/265
(97 %)
5 diff
(98.2 %id)
BE714295 head_neck .b 3846 to 4112 270 to 6       265/270
(98 %)
0 diff
(100 %id)
BE714298 head_neck .b 3846 to 4115 290 to 22       269/290
(92 %)
0 diff
(100 %id)
BE714396 head_neck .b 3846 to 4110 278 to 15       264/278
(94 %)
0 diff
(100 %id)
BU154782 melanotic melanoma, skin .b 3878 to 4627 27 to 781   tiling clone,   755/888
(85 %)
12 diff
(98.7 %id)
AI087856 pooled .b 3894 to 4331 440 to 3       438/440
(99 %)
0 diff
(100 %id)
AI638351 pooled germ cell tumors .b 3896 to 4330 462 to 28   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 435/435
(100 %)
2 diff
(99.6 %id)
AI470043 pooled .b 3898 to 4331 435 to 2       434/435
(99 %)
0 diff
(100 %id)
AI472140 pooled .b 3900 to 4330 444 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
AW051980 pooled .b 3934 to 4331 399 to 2       398/399
(99 %)
0 diff
(100 %id)
BE714250 head_neck .b 3941 to 4097 1 to 157       157/157
(100 %)
8 diff
(95.0 %id)
AA634996 lung, lung carcinoma .b 3976 to 4329 354 to 1     Submitted on the opposite strand 354/354
(100 %)
0 diff
(100 %id)
BQ955914 sciatic nerve .b 3993 to 4129 787 to 928       917/928
(98 %)
38 diff
(96.0 %id)
BM151073 leukopheresis .b 4010 to 4328 334 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 319/319
(100 %)
7 diff
(97.9 %id)
AI472618 pooled .b 4033 to 4241 210 to 1       210/210
(100 %)
3 diff
(98.6 %id)
BG613466 embryonal carcinoma, testis .b 4035 to 4086 662 to 716       698/913
(76 %)
58 diff
(93.7 %id)
AA435905   .b 4078 to 4335 258 to 1   fully sequenced,   258/258
(100 %)
3 diff
(98.9 %id)
AA214493 germinal center B cell .b 4145 to 4330 191 to 1   fully sequenced,   191/191
(100 %)
0 diff
(100 %id)
AA759020   .b 4161 to 4325 179 to 13       167/179
(93 %)
0 diff
(100 %id)
AI204264   .b 4229 to 4331 108 to 6       103/108
(95 %)
0 diff
(100 %id)
FN141203 breast carcinoma .b 4322 to 4419 96 to 1     Submitted on the opposite strand 96/104
(92 %)
1 diff
(99.1 %id)
BP421932 small intestine .b 4349 to 4857 1 to 509   tiling clone, Submitted on the opposite strand 509/509
(100 %)
0 diff
(100 %id)
BF433421 carcinoid, lung .b 4743 to 4877 1 to 134     Submitted on the opposite strand 134/140
(95 %)
3 diff
(97.9 %id)
BX090031 lung .b 4755 to 5129 21 to 395   tiling clone,   375/395
(94 %)
0 diff
(100 %id)
BU753556 placenta .b 4803 to 5315 530 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 513/513
(100 %)
4 diff
(99.3 %id)
AI668649 lung .b 4813 to 5314 498 to 1       498/498
(100 %)
11 diff
(97.8 %id)
AI445311 colon, moderately-differentiated adenocarcinoma .b 4887 to 5315 428 to 1   tiling clone,   428/428
(100 %)
2 diff
(99.6 %id)
N90286 lung .b 4892 to 5315 420 to 1       420/421
(99 %)
7 diff
(98.4 %id)
FN099088 breast carcinoma .b 5142 to 5257 1 to 115       115/115
(100 %)
8 diff
(93.1 %id)
BU168896 ductal carcinoma, cell line, Pancreas .c 1 to 834 6 to 844 S10L F22L A28P C143S V230Y ... tiling clone,   844/849
(99 %)
18 diff
(97.9 %id)
BG336846 choriocarcinoma, placenta .d -9 to 786 1 to 785 P5R A6E A7L S8P L9C ... tiling clone,   785/989
(79 %)
30 diff
(97.0 %id)
CN277500 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1 to 729 5 to 733   tiling clone,   730/733
(99 %)
0 diff
(100 %id)
AK310759 kidney, tumor tissue .e 1 to 913 9 to 922 exact tiling clone,   914/914
(100 %)
3 diff
(99.7 %id)
DB171563 kidney, tumor tissue .e 1 to 570 9 to 578   capped   570/570
(100 %)
1 diff
(99.9 %id)
AI651676 pooled germ cell tumors .e 313 to 784 471 to 1       471/471
(100 %)
5 diff
(99.0 %id)
BG188893   .e 323 to 785 1 to 461   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 461/461
(100 %)
7 diff
(98.5 %id)
BG206976   .e 323 to 786 1 to 458   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 458/458
(100 %)
7 diff
(98.5 %id)
BG210088   .e 324 to 783 1 to 459   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 459/459
(100 %)
14 diff
(97.0 %id)
BG199686   .e 325 to 781 1 to 457   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 457/459
(99 %)
13 diff
(97.2 %id)
BG209620   .e 325 to 790 1 to 466   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 466/467
(99 %)
14 diff
(97.1 %id)
BG185731   .e 326 to 785 1 to 459   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 459/460
(99 %)
8 diff
(98.3 %id)
BG186278   .e 326 to 784 1 to 458   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 458/458
(100 %)
2 diff
(99.6 %id)
BG186806   .e 326 to 784 1 to 458   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 458/458
(100 %)
5 diff
(99.0 %id)
BG195092   .e 326 to 784 1 to 458   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 458/458
(100 %)
3 diff
(99.4 %id)
BG207465   .e 326 to 799 1 to 473       473/490
(96 %)
4 diff
(99.2 %id)
BG221003   .e 326 to 784 4 to 462   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 459/462
(99 %)
9 diff
(98.1 %id)
BG191107   .e 327 to 784 1 to 457   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 457/457
(100 %)
3 diff
(99.4 %id)
BG215964   .e 327 to 784 4 to 461   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 458/461
(99 %)
7 diff
(98.5 %id)
BG218019   .e 327 to 784 1 to 457   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 457/457
(100 %)
2 diff
(99.6 %id)
AW290939   .e 374 to 784 428 to 18   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 411/411
(100 %)
1 diff
(99.8 %id)
AI085055 liver and spleen .e 377 to 781 402 to 1       402/409
(98 %)
16 diff
(96.1 %id)
AA483559 alveolar rhabdomyosarcoma .e 396 to 802 415 to 6   tiling clone,   410/415
(98 %)
0 diff
(100 %id)
AI301469 placenta .e 404 to 789 386 to 1       386/386
(100 %)
0 diff
(100 %id)
N55521 liver and spleen .e 485 to 784 300 to 1       300/304
(98 %)
0 diff
(100 %id)
AA678295 liver and spleen .e 606 to 784 179 to 1       179/179
(100 %)
0 diff
(100 %id)
BG197618   .f 1 to 615 59 to 676 A64S Y88H E91K K100N C109W ... tiling clone,   624/837
(74 %)
27 diff
(96.8 %id)
BM686689 eye, optic nerve .g-u 1 to 614 9 to 622   tiling clone, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 614/622
(98 %)
2 diff
(99.7 %id)
BU728046 eye, optic nerve .g-u 635 to 968 352 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 334/334
(100 %)
0 diff
(100 %id)
DA620367   .h 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
3 diff
(99.5 %id)
BM968800 lung, Primary Lung Epithelial Cells .i-u 235 to 915 698 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 681/681
(100 %)
1 diff
(99.9 %id)
CD652705 Embryonic Stem cells .j-u 1 to 787 7 to 789 exact tiling clone,   783/798
(98 %)
15 diff
(98.2 %id)
DB227634 trachea .k-u 1 to 553 2 to 555 exact tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
AA248220   .l 1 to 175 1 to 175 exact tiling clone,   175/175
(100 %)
0 diff
(100 %id)
AW054897 colon Gene BARD1, variant not shown         This clone was ignored    
TI_149275615   Gene BARD1, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i-u, .j-u, .k-u, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI